Library | SASB Sustainability Sector
Health Care
Refine
31 results
REFINE
SHOW: 16
Which discount rate for sustainability?
This report explores the appropriate discount rate for sustainability investments, advocating for a lower social discount rate for natural and social capital compared to financial capital. By applying this lower rate, companies could be incentivised to prioritise long-term investments in sustainability, ultimately supporting a balanced financial, social, and environmental value approach.
State of nature-related disclosures: Assessing TNFD alignment of nature-related disclosures by firms in high-risk sectors
The report evaluates the alignment of firms' nature-related disclosures with the TNFD framework. It covers eight priority sectors, highlighting disclosure gaps and providing recommendations for improvement to ensure comprehensive, high-quality nature-related reporting.
Business Council of Co-operatives and Mutuals (BCCM)
Business Council of Co-operatives and Mutuals (BCCM) is Australia's peak body for co-operatives and mutuals, across various sectors, including agriculture, banking, health, housing, and retail. Representing diverse sectors, BCCM advocates for sustainable business models, offering resources, research, and support.
Can investors save the planet? - NZAMI and fiduciary duty
The report evaluates asset managers' strategies aligning with the Race to Zero goal of limiting global warming while considering the possibility of a different climate scenario. It finds impactful environmental approaches might pose fiduciary challenges. Authors propose revising commitments to enhance climate impact while upholding fiduciary duties.
Climate scorpion – the sting is in the tail: Introducing planetary solvency
The report explores the risks and impact of climate change on a global scale. The report emphasises the need for a realistic risk assessment urgently and laying out a blueprint on developing a Planetary Solvency framework.
Assessing pharma companies’ response to COVID-19 and the threat of future pandemics
This report analyses pharmaceutical companies’ response during the initial stage of the COVID-19 pandemic, their performance in terms of registration and applying equitable access strategies for COVID-19 vaccines, voluntary licensing agreements and technology transfers, and forward-looking assessment of their preparedness for future epidemics and pandemics.
Constructive corporate engagements: From a corporate perspective
This research focuses on constructive corporate engagement. This report analyses survey results from 100 senior company directors and interviews with ten executives to examine the drivers of successful engagements. Insights include the importance of collaborating with companies, focusing on material issues, and using standard metrics for success.
Beyond diversity: Equity and inclusion as an overlooked opportunity for investors
This research identifies diversity, equity, and inclusion as instruments for creating stronger business performance and highlights the potential opportunity cost incurred by businesses and investors that overlook the possibility of equity and inclusion deficits.
Guidance and case studies for ESG integration: Equities and fixed income
The CFA Institute and Principles for Responsible Investment commissioned a survey on ESG integration, revealing that 56% of investors integrate governance into their equity analysis. Analysts may engage in ESG in fixed-income analysis to evaluate the risks and value of assets. ESG issues help investors arrive at estimates of fair stock value.
Navigating a new era of business and human rights
This book highlights the intersection of corporate practices and human rights. It explores evolving challenges, regulatory landscapes, and the importance of collaborative, ethical business conduct. Key themes include transparency, state roles, and the human rights-based approach, offering insights for stakeholders to navigate this complex field.
Are pharma companies addressing sexual and reproductive health access barriers for women and girls?
This report examines the role of pharmaceutical companies in addressing access barriers hindering women and girls’ sexual and reproductive health and rights (SRHR) globally. It assesses their research on new SRHR medicines and products, pricing strategies, company capacity building efforts, and inclusive business models.
Geopolitics of the energy transition: Critical materials
This paper explores strategic approaches for ensuring a sustainable energy transition by investigating the geopolitical aspects of critical materials including their supply chain, responsible efficiency, emergence of new technologies, their impact on labour rights, as well as suggesting ways to mitigate their risks and boost cooperation between countries.
User’s guide to IFC’s sustainability assessment and improvement tool for midsize growth companies
This tool aims to help small to mid-sized enterprises (SMEs) manage environmental and social risk and support long-term growth. The tool is contextualised for SMEs and provides comprehensive guidance focusing on environmental, social, and governance risk factors while presenting a pathway for manageable, systemic improvements.
Impact at work: An examination of corporate impact investing strategies and their durability
The report examines the durability of corporate impact investing strategies in advancing positive social, economic, and environmental outcomes while remaining financially sound. It explores impact themes, capital sources and risk-return strategies of corporates. The report concludes with recommendations to build and maintain impact investing programs over the long term.
Pensions and impact investing: How are National Advisory Boards (NABs) for impact investing engaging with pension funds to advance the market?
The Global Steering Group for Impact Investment (GSG) runs an Engaging with Pension Funds working group to support affiliated members to deepen their engagement with pension funds to advance the impact investment market. The report reflects case studies and examples gathered from members of the working group from 2021-2022.
Putting pandemics behind us: Investing in one health to reduce risks of emerging infectious diseases
This report discusses One Health, an approach that recognises the interdependent nature of human, animal, and environmental health. It presents an investment framework designed to mobilise finance for pandemic prevention and reduce the risks of emerging infectious diseases.